133 related articles for article (PubMed ID: 29441525)
1. Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
Kottner J; Jacobi L; Hahnel E; Alam M; Balzer K; Beeckman D; Busard C; Chalmers J; Deckert S; Eleftheriadou V; Furlan K; Horbach SER; Kirkham J; Nast A; Spuls P; Thiboutot D; Thorlacius L; Weller K; Williams HC; Schmitt J;
Br J Dermatol; 2018 Apr; 178(4):e279-e285. PubMed ID: 29441525
[TBL] [Abstract][Full Text] [Related]
2. Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).
Schmitt J; Deckert S; Alam M; Apfelbacher C; Barbaric J; Bauer A; Chalmers J; Chosidow O; Delamere F; Doney E; Eleftheriadou V; Grainge M; Johannsen L; Kottner J; Le Cleach L; Mayer A; Pinart M; Prescott L; Prinsen CA; Ratib S; Schlager JG; Sharma M; Thomas KS; Weberschock T; Weller K; Werner RN; Wild T; Wilkes SR; Williams HC
Br J Dermatol; 2016 Feb; 174(2):287-95. PubMed ID: 26779929
[TBL] [Abstract][Full Text] [Related]
3. Navigating the landscape of core outcome set development in dermatology.
Prinsen CAC; Spuls PI; Kottner J; Thomas KS; Apfelbacher C; Chalmers JR; Deckert S; Furue M; Gerbens L; Kirkham J; Simpson EL; Alam M; Balzer K; Beeckman D; Eleftheriadou V; Ezzedine K; Horbach SER; Ingram JR; Layton AM; Weller K; Wild T; Wolkerstorfer A; Williams HC; Schmitt J
J Am Acad Dermatol; 2019 Jul; 81(1):297-305. PubMed ID: 30878565
[TBL] [Abstract][Full Text] [Related]
4. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
[TBL] [Abstract][Full Text] [Related]
6. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
7. [Core outcome measurements in hand eczema trials : The HECOS initiative].
Rönsch H; Bauer A; Apfelbacher C
Hautarzt; 2019 Oct; 70(10):773-777. PubMed ID: 31359075
[TBL] [Abstract][Full Text] [Related]
8. Which outcomes have been measured in hand eczema trials? A systematic review.
Rönsch H; Apfelbacher C; Brans R; Matterne U; Molin S; Ofenloch R; Oosterhaven JAF; Schuttelaar MLA; Weisshaar E; Yew YW; Bauer A
Contact Dermatitis; 2019 Apr; 80(4):201-207. PubMed ID: 30632613
[TBL] [Abstract][Full Text] [Related]
9. Core outcome domains in incontinence-associated dermatitis research.
Van den Bussche K; Kottner J; Beele H; De Meyer D; Dunk AM; Ersser S; Lange T; Petrovic M; Schoonhoven L; Smet S; Van Damme N; Verhaeghe S; Van Hecke A; Beeckman D
J Adv Nurs; 2018 Jul; 74(7):1605-1617. PubMed ID: 29520848
[TBL] [Abstract][Full Text] [Related]
10. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
[TBL] [Abstract][Full Text] [Related]
11. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
[TBL] [Abstract][Full Text] [Related]
12. Including patients in core outcome set development: issues to consider based on three workshops with around 100 international delegates.
Young B; Bagley H
Res Involv Engagem; 2016; 2():25. PubMed ID: 29507761
[TBL] [Abstract][Full Text] [Related]
13. Creation of a core outcome set for clinical trials of people with shoulder pain: a study protocol.
Gagnier JJ; Page MJ; Huang H; Verhagen AP; Buchbinder R
Trials; 2017 Jul; 18(1):336. PubMed ID: 28728574
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the development of core set of domains of the core outcome set for patients with congenital melanocytic naevi (OCOMEN project).
Oei W; Fledderus AC; Korfage I; Eggen CAM; van der Horst CMAM; Spuls PI; Brinkmann SJH; Wolkerstorfer A; van Kessel M; Pasmans S
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):267-273. PubMed ID: 31419337
[TBL] [Abstract][Full Text] [Related]
15. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.
Schmitt J; Apfelbacher C; Spuls PI; Thomas KS; Simpson EL; Furue M; Chalmers J; Williams HC
J Invest Dermatol; 2015 Jan; 135(1):24-30. PubMed ID: 25186228
[TBL] [Abstract][Full Text] [Related]
16. Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting.
Dirr MA; Alam M; Apfelbacher C; Drewitz KP; Kang BY; Munblit D; Nekliudov N; Seylanova N
Arch Dermatol Res; 2023 Jul; 315(5):1375-1379. PubMed ID: 35244760
[TBL] [Abstract][Full Text] [Related]
17. Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative.
Singh JA; Dohm M; Sprowson AP; Wall PD; Richards BL; Gossec L; Hawker GA; Riddle DL; Buchbinder R
J Rheumatol; 2015 Dec; 42(12):2496-502. PubMed ID: 25834208
[TBL] [Abstract][Full Text] [Related]
18. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Trials; 2014 Dec; 15():511. PubMed ID: 25540987
[TBL] [Abstract][Full Text] [Related]
19. Core outcome domains for clinical trials in non-specific low back pain.
Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
[TBL] [Abstract][Full Text] [Related]
20. Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting.
Callis Duffin K; Gottlieb AB; Merola JF; Latella J; Garg A; Armstrong AW
J Rheumatol; 2017 May; 44(5):701-702. PubMed ID: 28461532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
